Effect of a new low-dosage oral contraceptive pill on blood electrolytes. A combined clinical and laboratory evaluation.
Fertil Steril
; 20(3): 405-13, 1969.
Article
en En
| MEDLINE
| ID: mdl-5769388
ABSTRACT
PIP Effects of a new low-dosage combination oral contraceptive containing .5 mg WY3707 (a progestational substance) plus .05 mg ethinyl estradiol were studied on 30 normal women. Findings based on 25 patients remaining in the study for 5 months indicate a weight gain (64%), a tendency to hypo- and oligomenorrhea (58.3%), headache (52%), dizziness (44%) and nausea (20%) as common side-effects. Blood pressure recordings were below 140/90 and had no major variations. Blood sodium and potassium levels, measured before therapy initiation and 2 and 5 months after use, showed no significant changes. Discussion centers on 20 previous studies relating oral contraceptives to blood electrolytes and pressure and weight and menstrual changes.^ieng
Palabras clave
Biology; Blood Pressure; Body Weight; Cardiovascular Effects; Contraception; Contraception Research; Contraceptive Agents, Estrogen; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents--administraction and dosage; Contraceptive Methods--side effects; Depression; Dizziness; Electrolyte Balance; Family Planning; Female Contraception; Fluid Balance; Headache; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Physiology; Potassium Ion Level; Progestins, Low-dose; Renin-angiotensin-aldosterone Effects; Research Methodology; Sodium Ion Level
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Potasio
/
Progestinas
/
Sodio
/
Anticonceptivos Orales
/
Etinilestradiol
Límite:
Female
/
Humans
Idioma:
En
Revista:
Fertil Steril
Año:
1969
Tipo del documento:
Article